Nurix Therapeutics Inc share price logo

Nurix Therapeutics Inc Share Price

NASDAQ: NRIX

Small Cap

$16.82

+0.14

(+0.84%)

Live

as on

Nurix Therapeutics Inc Stock Performance

as on April 28, 2026 at 3:10 am IST

  • Day's Low

    Day's High

    $16.52
    $17.14
    downward going graph

    1.78%

    Downside

    1.90%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $8.20
    $22.50
    downward going graph

    51.28%

    Downside

    33.77%

    Upside

    downward going graph

Nurix Therapeutics Inc share price movements today

Previous Close
$16.68
Open
$16.52
Volume
229.5K
Day's Low - High
$16.52 - $17.14
52 Week Low - High
$8.20 - $22.50

Nurix Therapeutics Inc Historical Returns

1 Month Return
+ 13.01 %
3 Month Return
-14.06 %
1 Year Return
+ 44.29 %
3 Year Return
+ 73.39 %
5 Year Return
-50.13 %

Nurix Therapeutics Inc Stock Fundamentals & Key Indicators

Check Nurix Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.7B

EPS (TTM)

-2.9372

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-307.3M

Revenue (TTM)

71.8M

Profit Margin

0.00%

Return On Equity TTM

-61.40%

Nurix Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Nurix Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Nurix Therapeutics Inc image
Nurix Therapeutics Inc
BUY$1.7B-50.13%NA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$40.8B116.23%131.78.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$109.5B99.64%28.132.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$33.4BNA121.785.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$79.5B52.82%18.1131.41%

Stock Returns calculator for Nurix Therapeutics Inc Stock including INR - Dollar returns

The Nurix Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Nurix Therapeutics Inc investment value today

Current value as on today

₹1,60,925

Returns

₹60,925

(+60.93%)

Returns from Nurix Therapeutics Inc Stock

₹45,502 (+45.5%)

Dollar Impact

₹15,424 (+15.42%)

Analyst Recommendation on Nurix Therapeutics Inc Stock

Based on 17 analysts

BUY

88.24%

Buy

11.76%

Hold

0.00%

Sell

Based on 17 analysts, 88.24% of analysts recommend a 'BUY' rating for Nurix Therapeutics Inc. Average target price of $30.24

Nurix Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Nurix Therapeutics Inc.

What analysts predicted

44.38%UPSIDE

Target Price

$30.24

Current Price

$16.82

Analyzed by

17 Analysts

Target

$30.24

Nurix Therapeutics Inc target price $30.24, a slight upside of 44.38% compared to current price of $16.82. According to 17 analysts rating.

Nurix Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Nurix Therapeutics Inc Stock has increased by 232% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:232% versus previous 30 day period

Nurix Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Nov 2023
Feb 2024
May 2024
Aug 2024
Nov 2024
Feb 2025
May 2025
Aug 2025
Nov 2025
Feb 2026
Total Revenue
15
16
12
12
13
18
44
7
13
6
Gross Profit
-34
-33
-36
-42
-53
-51
-34
2
8
-77
Operating Income
-45
-45
-48
-54
-64
-62
-48
-91
-83
-92
EBITDA
-44
-43
-46
-52
-63
-60
-46
-81
-68
-92
Interest Expense
7
-
-
-
-
-
-
-
-
-
Depreciation
3
3
4
4
4
4
5
5
4
3
Income Before Tax
-41
-41
-44
-48
-58
-56
-42
-86
-78
-87
Income Tax Expense
7
0
0
0
0
-
0
-
-
-
Net Income
-41
-41
-44
-48
-58
-56
-43
-86
-78
-87
Net Profit Margin
-276.77%
-250.33%
-368.39%
-388.91%
-440.75%
-305.38%
-98.66%
-1094.77%
-576.13%
-1394.34%

Nurix Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Nov 2018
Nov 2019
Nov 2020
Nov 2021
Nov 2022
Nov 2023
Nov 2024
Nov 2025
Total Revenue
37
31
17
29
38
76
54
83
Gross Profit
-3
-13
17
29
38
-112
-167
65
Operating Income
-9
-22
-64
-117
-183
-155
-213
-285
EBITDA
-6
-19
-62
-111
-173
-148
-205
-244
Interest Expense
0
0
3
6
14
-
-
-
Depreciation
2
2
2
6
10
13
16
18
Income Before Tax
-8
-21
-63
-117
-180
-143
-193
-263
Income Tax Expense
0
0
-20
0
-14
13
0
0
Net Income
-9
-21
-43
-117
-166
-143
-193
-264
Net Profit Margin
-25.18%
-69.74%
-242.66%
-393.93%
-429.87%
-186.98%
-354.85%
-314.90%

Nurix Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Feb 2024
May 2024
Aug 2024
Nov 2024
Feb 2025
May 2025
Aug 2025
Nov 2025
Feb 2026
Net Income
-41
-44
-48
-58
-56
-43
-86
-78
-87
Operating Cash Flow
-41
-39
-42
-48
-61
-63
-57
-67
-71
Investing Cash Flow
35
-131
-21
-140
25
71
50
0
-123
Financing Cash Flow
1
237
45
200
1
0
1
236
19
Change in Cash
-4
66
-17
10
-34
8
-5
168
-175

Nurix Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Nov 2019
Nov 2020
Nov 2021
Nov 2022
Nov 2023
Nov 2024
Nov 2025
Net Income
-21
-43
-117
-180
-143
-193
-264
Operating Cash Flow
0
0
-84
-159
-81
-172
-249
Investing Cash Flow
8
-254
-108
27
68
-257
147
Financing Cash Flow
0
339
153
117
3
485
238
Change in Cash
9
84
-38
-15
-9
55
137

Global Institutional Holdings in Nurix Therapeutics Inc

Funds
Holdings
BlackRock Inc
6.54%
FMR Inc
4.09%
Redmile Group, LLC
3.58%
Redmile Group, LLC
7.83%
ARK Investment Management LLC
2.06%
See all

Insights on Nurix Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, NRIX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, NRIX stock has moved up by 39.2%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, NRIX has outperformed top 5 stocks with highest market-cap in its industry

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 13.57M → 6.25M (in $), with an average decrease of 54.0% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -78.22M → -87.17M (in $), with an average decrease of 11.5% per quarter

About Nurix Therapeutics Inc

Nurix Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases. The company develops NX-5948, an orally bioavailable BTK degrader, that is in Phase 2 clinical trials for the treatment of relapsed or refractory B-cell malignancies and autoimmune diseases; NX-2127, an orally bioavailable Bruton's tyrosine kinase (BTK) degrader, that is in Phase Phase 1a/1b clinical trials for the treatment of relapsed or refractory B-cell malignancies; and NX-1607, an orally bioavailable Casitas B-lineage lymphoma proto-oncogene-B (CBL-B) inhibitor, that is in Phase 1a/1b clinical trials to treat immuno-oncology indications. It is also developing NX-0479/GS-6791, a IRAK4 degrader for the treatment of rheumatoid arthritis and other inflammatory diseases. The company has a strategic collaboration agreement with Gilead Sciences, Inc. (Gilead), Sanofi S.A. (Sanofi), and Pfizer Inc. (Pfizer) for co-development and co-commercialization for multiple drug candidates. The company was formerly known as Nurix Inc. and changed its name to Nurix Therapeutics, Inc. in October 2018. Nurix Therapeutics, Inc. was incorporated in 2009 and is headquartered in Brisbane, California.
OrganisationNurix Therapeutics Inc
Headquarters1600 Sierra Point Parkway, Brisbane, CA, United States, 94005
IndustryBiotechnology
CEODr. Arthur T. Sands M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Nurix Therapeutics Inc

Name

Title

Dr. John Kuriyan Ph.D.

Founder & Member of Scientific Advisory Board

Rita Kwong

Senior Accounting Manager

Dr. Pasit Phiasivongsa Ph.D.

Chief Technical Officer

Mr. Christopher B. Phelps Ph.D.

Senior VP & Head of Early Drug Discovery

Dr. Arthur T. Sands M.D., Ph.D.

CEO, President & Director

Mr. Johannes Van Houte

Chief Financial Officer

Dr. Gwenn M. Hansen Ph.D.

Chief Scientific Officer

Dr. Christine Ring J.D., Ph.D.

Chief Legal Officer, Secretary & Chief Compliance Officer

Dr. Arthur Weiss M.D., Ph.D.

Founder & Member of Scientific Advisory Board

Dr. Jason Kantor Ph.D.

Chief Business Officer

FAQs

What is Nurix Therapeutics Inc share price today?

Nurix Therapeutics Inc share price today is $16.82 as on . Nurix Therapeutics Inc share today touched a day high of $17.14 and a low of $16.52.

What is the 52 week high and 52 week low for Nurix Therapeutics Inc share?

Nurix Therapeutics Inc share touched a 52 week high of $22.5 on and a 52 week low of $8.2 on . Nurix Therapeutics Inc stock price today i.e. is trending at $16.82,which is 25.24% down from its 52 week high and 105.25% up from its 52 week low.

What is Nurix Therapeutics Inc's market capitalisation today?

Nurix Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Nurix Therapeutics Inc Stock (NRIX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Nurix Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Nurix Therapeutics Inc Shares that will get you 0.0892 shares as per Nurix Therapeutics Inc share price of $16.82 per share as on April 27, 2026 at 9:40 pm IST.

What is the minimum amount required to buy Nurix Therapeutics Inc Stock (NRIX) from India?

Indian investors can start investing in Nurix Therapeutics Inc (NRIX) shares with as little as ₹94.19 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹941.90 in Nurix Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Nurix Therapeutics Inc share’s latest price of $16.82 as on April 27, 2026 at 9:40 pm IST, you will get 0.5945 shares of Nurix Therapeutics Inc. Learn more about fractional shares .

What are the returns that Nurix Therapeutics Inc has given to Indian investors in the last 5 years?

Nurix Therapeutics Inc stock has given -50.13% share price returns and 26.36% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?